Fig. 3

Effect of haloperidol on human brain organoids treated with haloperidol and sodium propionate (a) Light microscope images of brain organoids treated with haloperidol (HAL) and sodium propionate (PRO) from 35 d – 63 d. Scale bars, 200 μm. (b) Quantification for brain organoid size after HAL and PRO treatment from 35 d – 63 d using surface area and diameter measurements. Values represent mean ± IQR (n ≥ 6). (c) Immunostaining for DAPI (blue), SOX2 (red) and TUJ1 (green) of brain organoids treated with HAL and PRO (300µM) on 63 d. Scale bars, 50 μm. (d) Quantification of the thickness of VZ-like regions and neuronal layers of organoids treated with HAL and PRO (300µM) on 63 d. Values represent mean ± IQR (n = 5 cortical structures from three organoids). ns; non-significant. ∗p < 0.05.